Annual Current Liabilities
$13.63 M
+$3.81 M+38.78%
December 31, 2023
Summary
- As of February 8, 2025, PDSB annual total current liabilities is $13.63 million, with the most recent change of +$3.81 million (+38.78%) on December 31, 2023.
- During the last 3 years, PDSB annual current liabilities has risen by +$10.36 million (+316.77%).
- PDSB annual current liabilities is now at all-time high.
Performance
PDSB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$18.34 M
+$2.67 M+17.00%
September 30, 2024
Summary
- As of February 8, 2025, PDSB quarterly total current liabilities is $18.34 million, with the most recent change of +$2.67 million (+17.00%) on September 30, 2024.
- Over the past year, PDSB quarterly current liabilities has increased by +$4.71 million (+34.56%).
- PDSB quarterly current liabilities is now -43.27% below its all-time high of $32.33 million, reached on March 31, 2018.
Performance
PDSB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PDSB Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.8% | +34.6% |
| 3 y3 years | +316.8% | +132.0% |
| 5 y5 years | +113.6% | +132.0% |
PDSB Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +262.9% | at high | +388.3% |
| 5 y | 5-year | at high | +387.9% | at high | +625.9% |
| alltime | all time | at high | +662.2% | -43.3% | +625.9% |
PDS Biotechnology Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.34 M(+17.0%) |
| Jun 2024 | - | $15.67 M(+4.1%) |
| Mar 2024 | - | $15.06 M(+10.5%) |
| Dec 2023 | $13.63 M(+38.8%) | $13.63 M(+48.9%) |
| Sep 2023 | - | $9.15 M(+15.8%) |
| Jun 2023 | - | $7.90 M(+91.4%) |
| Mar 2023 | - | $4.13 M(-58.0%) |
| Dec 2022 | $9.82 M(+161.5%) | $9.82 M(+102.9%) |
| Sep 2022 | - | $4.84 M(+7.2%) |
| Jun 2022 | - | $4.52 M(-10.0%) |
| Mar 2022 | - | $5.02 M(+33.6%) |
| Dec 2021 | $3.76 M(+14.8%) | $3.76 M(+5.0%) |
| Sep 2021 | - | $3.58 M(-10.6%) |
| Jun 2021 | - | $4.00 M(+36.7%) |
| Mar 2021 | - | $2.93 M(-10.4%) |
| Dec 2020 | $3.27 M(+17.1%) | $3.27 M(+12.8%) |
| Sep 2020 | - | $2.90 M(+14.7%) |
| Jun 2020 | - | $2.53 M(-37.6%) |
| Mar 2020 | - | $4.05 M(+44.9%) |
| Dec 2019 | $2.79 M | $2.79 M(-23.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $3.64 M(-14.6%) |
| Jun 2019 | - | $4.27 M(-22.9%) |
| Mar 2019 | - | $5.54 M(-13.2%) |
| Dec 2018 | $6.38 M(-50.4%) | $6.38 M(-4.6%) |
| Sep 2018 | - | $6.69 M(-51.8%) |
| Jun 2018 | - | $13.87 M(-57.1%) |
| Mar 2018 | - | $32.33 M(+151.3%) |
| Dec 2017 | $12.87 M(+92.5%) | $12.87 M(+10.0%) |
| Sep 2017 | - | $11.70 M(+1.0%) |
| Jun 2017 | - | $11.59 M(+71.8%) |
| Mar 2017 | - | $6.75 M(+0.9%) |
| Dec 2016 | $6.68 M(-22.2%) | $6.68 M(+57.2%) |
| Sep 2016 | - | $4.25 M(-37.1%) |
| Jun 2016 | - | $6.76 M(+2.9%) |
| Mar 2016 | - | $6.57 M(-23.5%) |
| Dec 2015 | $8.59 M(+120.6%) | $8.59 M(+1.7%) |
| Sep 2015 | - | $8.45 M(+109.7%) |
| Jun 2015 | - | $4.03 M(+3.5%) |
| Dec 2014 | $3.89 M(+117.7%) | $3.89 M |
| Dec 2013 | $1.79 M | - |
FAQ
- What is PDS Biotechnology annual total current liabilities?
- What is the all time high annual current liabilities for PDS Biotechnology?
- What is PDS Biotechnology annual current liabilities year-on-year change?
- What is PDS Biotechnology quarterly total current liabilities?
- What is the all time high quarterly current liabilities for PDS Biotechnology?
- What is PDS Biotechnology quarterly current liabilities year-on-year change?
What is PDS Biotechnology annual total current liabilities?
The current annual current liabilities of PDSB is $13.63 M
What is the all time high annual current liabilities for PDS Biotechnology?
PDS Biotechnology all-time high annual total current liabilities is $13.63 M
What is PDS Biotechnology annual current liabilities year-on-year change?
Over the past year, PDSB annual total current liabilities has changed by +$3.81 M (+38.78%)
What is PDS Biotechnology quarterly total current liabilities?
The current quarterly current liabilities of PDSB is $18.34 M
What is the all time high quarterly current liabilities for PDS Biotechnology?
PDS Biotechnology all-time high quarterly total current liabilities is $32.33 M
What is PDS Biotechnology quarterly current liabilities year-on-year change?
Over the past year, PDSB quarterly total current liabilities has changed by +$4.71 M (+34.56%)